-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Leukemia, Myelogenous, Chronic, BCR-ABL Positive are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Cancer-drug discovery and cardiovascular surveillance.
Groarke JD, Cheng S, Moslehi J
(2013) N Engl J Med 369: 1779-81 - Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?
Arteaga CL, Baselga J
(2004) Cancer Cell 5: 525-31 - Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O
(2008) J Clin Oncol 26: 5728-34 - Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.
Moslehi JJ, Deininger M
(2015) J Clin Oncol 33: 4210-8 - A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS
(1998) Genes Dev 12: 968-81 - Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway.
Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM
(1998) Genes Dev 12: 1415-24 - Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
Gishizky ML, Cortez D, Pendergast AM
(1995) Proc Natl Acad Sci U S A 92: 10889-93 - Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements.
Zutter MM, Painter AA, Staatz WD, Tsung YL
(1995) Blood 86: 3006-14 - Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
McGlave PB, Shu XO, Wen W, Anasetti C, Nademanee A, Champlin R, Antin JH, Kernan NA, King R, Weisdorf DJ
(2000) Blood 95: 2219-25 - Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.
Manouchehri A, Kanu E, Mauro MJ, Aday AW, Lindner JR, Moslehi J
(2020) Arterioscler Thromb Vasc Biol 40: 301-308 - Chronic Myelogenous Leukemia, Version 1.2014.
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H, Ntational comprehensive cancer network
(2013) J Natl Compr Canc Netw 11: 1327-40 - Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
Grumbach IM, Mayer IA, Uddin S, Lekmine F, Majchrzak B, Yamauchi H, Fujita S, Druker B, Fish EN, Platanias LC
(2001) Br J Haematol 112: 327-36 - Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase-FISH study.
el-Rifai W, Ruutu T, Vettenranta K, Temtamy S, Knuutila S
(1996) Br J Haematol 92: 365-9 - Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation.
Ikpeazu C, Davidson MK, Halteman D, Browning PJ, Brandt SJ
(2000) Biol Blood Marrow Transplant 6: 301-8 - Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells.
Burger SR, Zutter MM, Sturgill-Koszycki S, Santoro SA
(1992) Exp Cell Res 202: 28-35 - Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.
Zheng W, Linet MS, Shu XO, Pan RP, Gao YT, Fraumeni JF
(1993) Cancer Causes Control 4: 361-8 - Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R, Maeda Y, Sato Y, Okabe S, Inukai T, Sugita K, Wilson MH, Rooney CM, Koike K
(2014) Cytotherapy 16: 1257-69 - Juvenile chronic myelogenous leukemia.
Hess JL, Zutter MM, Castleberry RP, Emanuel PD
(1996) Am J Clin Pathol 105: 238-48 - Peripheral blood leucocytes ornithine decarboxylase activity in chronic myeloid leukemia patients: prognostic and therapeutic implications.
Tripathi AK, Chaturvedi R, Ahmad R, Asim M, Sawlani KK, Singh RL, Tekwani BL
(2002) Leuk Res 26: 349-54 - Flow cytometric analysis of aneuploidy and S-phase fraction in chronic myeloid leukemia patients: role in early detection of accelerated phase.
Tripathi AK, Chaturvedi R, Ahmad R, Asim M, Sawlani KK, Singh MK, Tripathi P, Tekwani BL
(2003) Leuk Res 27: 899-902 - Update on the diagnosis of and therapy for acute promyelocytic leukemia and chronic myelogenous leukemia.
Wujcik D
(1996) Oncol Nurs Forum 23: 478-87 - Mobilization of Ph chromosome-negative peripheral blood stem cells in a child with chronic myeloid leukemia after imatinib-induced complete molecular remission.
Woods-Swafford W, Vnencak-Jones CL, Loken MR, Manes B, Frangoul H
(2008) Pediatr Blood Cancer 50: 639-41 - Severe ehrlichia infection in pediatric oncology and stem cell transplant patients.
Esbenshade A, Esbenshade J, Domm J, Williams J, Frangoul H
(2010) Pediatr Blood Cancer 54: 776-8 - Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy.
Dwyer JP, Yates KM, Sumner EL, Stone WJ, Wang Y, Koury MJ, Fogo AB, Zent R
(2007) Clin Nephrol 67: 176-81 - Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R, Tripathi AK, Tripathi P, Singh S, Singh R, Singh RK
(2008) In Vivo 22: 525-8 - Chronic idiopathic neutrophilia: experience and recommendations.
Weir AB, Lewis JB, Arteta-Bulos R
(2011) South Med J 104: 499-504
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
